Elevated circulating level of osteopontin is associated with advanced disease state of non-small cell lung cancer
- 21 May 2007
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 57 (3) , 373-380
- https://doi.org/10.1016/j.lungcan.2007.04.005
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with boneCancer and Metastasis Reviews, 2006
- Runx2 phosphorylation induced by fibroblast growth factor‐2/protein kinase C pathwaysProteomics, 2006
- Osteopontin: role in cell signaling and cancer progressionTrends in Cell Biology, 2006
- Osteopontin Expression and Prognostic Significance in Non–Small Cell Lung CancerClinical Cancer Research, 2005
- Overexpression of Osteopontin Is Associated with More Aggressive Phenotypes in Human Non–Small Cell Lung CancerClinical Cancer Research, 2005
- Control of RUNX2 isoform expression: The role of promoters and enhancersJournal of Cellular Biochemistry, 2005
- Six Genes Expressed in Bones and Teeth Encode the Current Members of the SIBLING Family of ProteinsConnective Tissue Research, 2003
- Characterization of an Osteoblast-specific Enhancer Element in the CBFA1 GeneJournal of Biological Chemistry, 2002
- Expression, roles, receptors, and regulation of osteopontin in the kidneyKidney International, 2001
- OsteopontinCritical Reviews in Oral Biology & Medicine, 2000